Vitamin markets: Vitamin E – stable but suppliers actively trying to hike prices
Vitamin E prices have remained relatively stable, though suppliers are actively attempting to increase prices through tactics like announcing hikes and limiting availability.
In partnership with Feed Additive Prices
Vitamin E 50%
Vitamin E prices have remained relatively stable, though suppliers are actively attempting to increase prices through tactics like announcing hikes and limiting availability. Despite this, the current supply appears adequate as actual trade does not support these increases. Prices have slightly declined in recent months but have recently stabilized without the desired manufacturers rises. One Western supplier is under force majeure and is unlikely to resolve this situation before the summer of 2025. At the same time that supplier is looking into expanding production capacity. The first quarter contracts are secured with a small portion of the second quarter also in place.
Vitamin A 1000
The market is currently stable after previous price declines, but the outlook remains weak due to expected increased capacity from China and a Western supplier still under force majeure. Although some aroma chemicals have had the force majeure lifted, the resolution for vitamin A is anticipated by April 2025. The market feels calm, with buyers avoiding long-term bookings and first-quarter contracts already secured.
Vitamin D3 500
Vitamin D3 prices remain high due to ongoing material shortages and firm supplier pricing. A recent price hike from a major supplier has led buyers to shift from a wait-and-see strategy to actively securing additional volume in the first quarter, as the likelihood of a short-term price drop appears unlikely with much of the quarter’s supply already contracted.
Vitamin B2 80%
Although manufacturers still express a desire to raise prices, the market remains stable and appears well-balanced. In Europe, a slight decline in prices has even been observed, while in other regions, prices have remained consistent for an extended period. No significant changes are anticipated in the near future, and the first quarter is now fully contracted.
D-Calpan
In all regions, the market remains quite stable regarding actual transaction prices and the market price continues to be low. While some key suppliers of d-calpan are eager to see prices rise, the prevailing oversupply has so far prevented a shift from the current pricing structure, and no significant changes are anticipated in the near future. The first quarter and part of the second quarter are already contracted.
Vitamin B3
Vitamin B3 prices have remained stable to weak, with some suppliers looking to increase prices while others focus on maintaining market share. This has led to a slight overall price decrease in most regions. While Q1 contracts are secured, buyers are hesitant to commit to Q2 volumes.
Biotin
The biotin market has remained stable for several months, continuing to hover at a historically low level. Suppliers have made multiple attempts to raise prices, yet none have succeeded thus far. Currently, the market appears balanced, and no significant changes are anticipated in the near future. Contracts for Q1 are secured, along with a portion of Q2.
Vitamin C 35% mono
The eagerness of suppliers to raise prices is evident, whether through actual price hikes or by withholding offers. Currently, the market appears to be oversupplied, as prices have not risen compared to the higher prices seen in late 2024. This situation has created a patience game between suppliers and buyers, as the market remains stable with little expected nearby change. A significant portion of Q1 and Q2 has already been contracted.
